BIOMET 3i Introduces Expanded Indications And New Packaging For Endobon® Xengraft Granules
BIOMET 3i announced today that Endobon® Xenograft Granules are now cleared for use in sinus elevation procedures and are also available in convenient, easy-to-use packaging for safety and value.
Endobon® Xenograft Granules are hydroxyapatite ceramic derived from cancellous bovine bone and are fully deproteinated by a two-step high temperature manufacturing process for safety from bacteria, viruses and prions. The granules contain osseoconductive properties that facilitate bone growth directly on the ceramic surface and through the entire graft, and are designed to facilitate maximum bone volume retention.
Endobon® Xenograft Granules have more than 10 years of combined use in oral maxillofacial and orthopedic procedures and are available in large and small granule sizes to accommodate the defect size that the clinician is treating.
The NEW Endobon® Xenograft Granules packaging features:Easy-to-open dishes; particles don’t stick to the lid
A sturdy, inner dish that is easier to open without spilling material
A dish that doubles as a dappen dish, which can be placed directly into the sterile field
Convenient value packs of individually sealed 1.0ml dishes for the large granule sites
A red dot on the label to indicate sterility of every pack
About BIOMET 3iBIOMET 3i, a division of Biomet, Inc., is a leading manufacturer of dental implants, abutments and related products. Since its inception in 1987, BIOMET 3i has been on the forefront in developing, manufacturing and distributing oral reconstructive products, including dental implant components and bone and tissue regenerative materials. The company also provides educational programs and seminars for dental professionals around the world. BIOMET 3i is based in Palm Beach Gardens, Florida, with operations throughout North America, Latin America, Europe and Asia-Pacific. For more information about BIOMET 3i, please visit www.biomet3i.com or contact the company at (800) 342-5454; outside the U.S. dial (561) 776-6700.